DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical Preparations
RARE
ULTRAGENYX PHARMACEUTICAL IN
322 institutions still hold ULTRAGENYX PHARMACEUTICAL IN as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 90400D108·Pharmaceutical Preparations·322 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
322 institutions reported RARE in Q1 2026. BlackRock, Inc. leads at 12.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 17
302 more holders available. Log in →